Spandidos Publications style
Oliveras-Ferraros C, Vall-Llovera AM, Vazquez-Martin A, Salip DC, Queralt B, Cufí S, Martin-Castillo B, Bosch-Barrera J, Brunet J, De Llorens R, De Llorens R, et al: Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment. Oncol Rep 27: 1887-1892, 2012.
APA
Oliveras-Ferraros, C., Vall-Llovera, A.M., Vazquez-Martin, A., Salip, D.C., Queralt, B., Cufí, S. ... Menendez, J.A. (2012). Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment. Oncology Reports, 27, 1887-1892. https://doi.org/10.3892/or.2012.1732
MLA
Oliveras-Ferraros, C., Vall-Llovera, A. M., Vazquez-Martin, A., Salip, D. C., Queralt, B., Cufí, S., Martin-Castillo, B., Bosch-Barrera, J., Brunet, J., De Llorens, R., Menendez, J. A."Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment". Oncology Reports 27.6 (2012): 1887-1892.
Chicago
Oliveras-Ferraros, C., Vall-Llovera, A. M., Vazquez-Martin, A., Salip, D. C., Queralt, B., Cufí, S., Martin-Castillo, B., Bosch-Barrera, J., Brunet, J., De Llorens, R., Menendez, J. A."Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment". Oncology Reports 27, no. 6 (2012): 1887-1892. https://doi.org/10.3892/or.2012.1732
